NRXP / NRx Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

NRx 製藥公司

已發行股份 36,196,097 shares
內部人士股份12,105,873 shares
內部持股33.45 %
所有內部人士26
內部人士情緒分數

「內部人士情緒分數」用於查找被公司內部人士購入的公司。

它是一個複雜的多因素量化模型的結果,該模型能夠辨識具有最高內部人士累積持有水平的公司。該評分模型結合了內部人士在過去90天內購買的淨數量、總購買股份佔流通股比例,以及內部人士擁有的總股份的指標。該分數的範圍從0到100,數值越高表示相對於同行業而言具有更高程度的內部人士持股水平,50為平均值。

更新頻率:每日

查閱「內部人士首選」,該清單呈現被內部人士購入最多的公司。

高管情緒分數

「高管情緒分數」用於查找被公司管理層購入的公司。

根據定義,公司高管是公司內部人士,但與其他內部人士(10%的股東和董事會成員)不同,公司高管每天在公司工作,而且他們使用自己的資金進行交易。(10%的股東和董事會成員通常是基金經理,管理著其他人的資金。)因此,公司高管進行的內幕交易更為重要性,應該被適當地重視和關注。

如同「內部人士情緒分數」,「高管情緒分數」也是一個複雜的多因素量化模型的計算結果,該模型能夠辨識具有最高高管累積持有水平的公司。

更新頻率:每日

查閱「內部人士首選」,該清單呈現被內部人士購入最多的公司。

關鍵內部人士指標

此表格顯示了公司在各種內部人士指標上的排名。百分位數排名顯示了這家公司在美國市場與其他公司相比的表現。排名越高表明公司所處狀況越好。

舉例來說,一般認為內部人士的買入是一個積極的指標,因此具有更多內部人士買入的公司將排名高於那些內部人士買入較少(甚至有內部人士賣出)的公司。

內部人士買入淨數(排名)

0 ( )
4562 out of 10931

內部人士買入淨數是過去90天內買入的內部人士總數減去賣出的內部人士總數。以百分位排名顯示(範圍從0到100%)。

內部人士買入佔流通股比例(排名)

0.000% ( )
4512 out of 10788

內部人士買入佔流通股比例是內部人士在過去90天內購買的股份總數減去賣出的股份總數,除以總流通股數並乘以100。

內幕交易圖表

以下圖表顯示了NRx Pharmaceuticals, Inc.內部人士交易。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。

內部人員名單及盈利指標

這張表格顯示已知的內部人員名單,從向SEC披露的申報文件中自動生成。除了姓名、最近的職稱和董事、高管或10%擁有人的標誌外,我們還提供了最新披露的持股信息。此外,我們盡可能提供內部人的歷史交易表現。歷史交易表現是內部人士實際進行的公開市場購買交易表現的加權平均值。有關此計算方式的更多資訊,請查看YouTube網絡研討會

See our leaderboard of most profitable insider traders.

內部人士 平均收益(%) 持股
數量
分拆
調整
Richard Ackerman President & CEO, Director, 10% Owner - [D] [O] [10%] 519,315 519,315
B Group, Inc. 10% Owner - [10%] 6,000,000 6,000,000
Richard Birdoff Director - [D] 0 0
BRAC Lending Group LLC 10% Owner - [10%] 590,435 590,435
Robert Besthof Chief Comm. & Patient Officer - [O] 23,710 2,371
Big Rock Partners Sponsor, LLC 10% Owner - [10%] 519,315 519,315
Alessandra Daigneault General Counsel & Secretary - [O] 31,584 3,158
Michael Fong Director - [D] 0 0
內部人士 平均收益(%) 持股
數量
分拆
調整
Patrick John Flynn Director - [D] 1,750 175
Sharon Glied Director - [D] 13,168 1,317
Aaron Gorovitz Director - [D] 105,000 10,500
Chaim Hurvitz Director - [D] 2,214,793 221,479
Javitt Daniel C. 10% Owner - [10%] 9,634,793 963,479
Jonathan C Javitt Chairman and Chief Scientist, Director, 10% Owner - [D] [O] [10%] 1,516,834 1,516,834
Bennett Kim 0
Koenig Stuart F. Director - [D] 0 0
Steven Levine 10% Owner - [10%] 1,776,000 1,776,000
內部人士 平均收益(%) 持股
數量
分拆
調整
Herbert Raymond McMaster Director - [D] 18,300 1,830
David M Nussbaum 10% Owner - [10%] 1,776,000 1,776,000
Polar Asset Management Partners Inc. 10% Owner - [10%] 488,036 488,036
Rex Albert G. Director - [D] 0 0
Troy T Taylor Director - [D] 0 0
Daniel Troy Director - [D] 43,093 4,309
Voorhees Seth Van CHIEF FINANCIAL OFFICER - [O] 16,337 1,634
Stephen H Willard CHIEF EXECUTIVE OFFICER, Director - [D] [O] 50,000 5,000
Lori Wittman CFO, Director - [D] [O] 0 0

Report errors via our new Insider Auditing Tool

追蹤內部人士買入記錄 - 短期收益分析

在這一部分,我們分析了在 NRXP / NRx Pharmaceuticals, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況, 結果僅為理論值。 .

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 內部人士 報告
股數
報告
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2024-12-17 Javitt Jonathan C 40,000 1.1700 40,000 1.1700 46,800 28 5.1000 157,200 335.90
2023-08-30 Gorovitz Aaron 35,000 0.3199 3,500 3.1990 11,196
2023-08-30 Hurvitz Chaim 70,000 0.2875 7,000 2.8750 20,125
2023-08-23 Javitt Jonathan C 100,000 0.3300 10,000 3.3000 33,000
2023-08-22 Javitt Jonathan C 200,000 0.3220 20,000 3.2200 64,400
2022-12-16 Willard Stephen H 50,000 1.1700 5,000 11.7000 58,500
2022-11-28 Flynn Patrick John 2,500 1.2500 250 12.5000 3,125
2022-11-28 Flynn Patrick John 2,500 1.2400 250 12.4000 3,100
2022-11-28 Flynn Patrick John 1,750 1.2500 175 12.5000 2,188

經調整價格 已按拆股調整。 經調整股數 已按拆股調整。

NRXP / NRx Pharmaceuticals, Inc. Insider Trades
追蹤內部人士賣出記錄 - 短期虧損分析

在這一部分,我們分析了在 NRXP / NRx Pharmaceuticals, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況, 結果僅為理論值。 .

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 內部人士 報告
股數
報告
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
2022-12-07 Javitt Jonathan C 400,000 1.0000 40,000 10.0000 400,000 292 0.2317 -390,732 -97.68
2022-07-29 Javitt Daniel C. 784,063 1.0094 78,406 10.0940 791,433
2022-06-07 Javitt Daniel C. 86,459 0.6461 8,646 6.4610 55,861
2022-06-06 Javitt Daniel C. 115,657 0.6653 11,566 6.6530 76,947
2022-06-03 Javitt Daniel C. 243,596 0.7024 24,360 7.0240 171,102
2021-09-15 Besthof Robert 40,000 11.7600 4,000 117.6000 470,400
2021-08-23 Daigneault Alessandra 33,715 13.1100 3,372 131.1000 442,004
2020-03-13 Polar Asset Management Partners Inc. 29,464 10.6000 5,357 58.3000 312,318
2018-11-20 ACKERMAN RICHARD 1,500,000 272,727

經調整價格 已按拆股調整。 經調整股數 已按拆股調整。

NRXP / NRx Pharmaceuticals, Inc. Insider Trades
交易歷史

點擊連結圖示即可查看完整的交易記錄。作為 10b5-1 自動交易計畫的一部分進行報告的交易,將在標記為 10b-5 的欄位中顯示 X。

呈報
日期
交易
日期
表格 內部人士 證券代碼 證券種類 代碼 10b5-1 直接 行使
價格
單位
價格
股數
變化
價值
變化 (1K)
剩餘
期權
剩餘
股份
2025-08-21 3 B Group, Inc. See Note 1 NRXP Common Stock I 3,000,000
2024-12-18 2024-12-17 4 Javitt Jonathan C NRXP Common Stock P - Purchase D 1.1700 40,000 47 84,634
2023-09-11 2023-08-30 4 Gorovitz Aaron By Spouse NRXP Common Stock, par value $0.001 per share P - Purchase I 0.3199 35,000 11 105,000
2023-09-11 2023-08-30 4 Hurvitz Chaim NRXP Common Stock, par value $0.001 per share P - Purchase D 0.2875 70,000 20 570,000
2023-08-24 2023-08-23 4 Javitt Jonathan C NRXP Common Stock P - Purchase D 0.3300 100,000 33 446,332
2023-08-23 2023-08-22 4 Javitt Jonathan C NRXP Common Stock P - Purchase D 0.3220 200,000 64 346,332
2023-02-14 2022-12-14 5 Javitt Jonathan C By Trust NRXP Common Stock, par value $0.001 per share G - Gift I -300,000 14,468,329
2022-12-19 2022-12-16 4 Willard Stephen H NRXP Common Stock, par value $0.001 per share P - Purchase D 1.1700 50,000 58 50,000
2022-12-19 2022-12-16 4 VAN VOORHEES SETH NRXP Common Stock, par value $0.001 per share P - Purchase D 1.1000 30,000 33 46,337
2022-12-19 2022-11-25 4/A VAN VOORHEES SETH NRXP Common Stock, par value $0.001 per share P - Purchase D 1.1100 7,021 8 16,337
2022-12-19 2022-11-25 4/A VAN VOORHEES SETH NRXP Common Stock, par value $0.001 per share P - Purchase D 1.1000 600 1 9,316
2022-12-19 2022-11-25 4/A VAN VOORHEES SETH NRXP Common Stock, par value $0.001 per share P - Purchase D 1.1200 8,716 10 8,716
2022-12-09 2022-12-07 4 Javitt Jonathan C By Trust NRXP Common Stock, par value $0.001 per share S - Sale I 1.0000 -400,000 -400 12,899,997
2022-12-01 2022-11-30 4 Javitt Daniel C. by Glytech LLC NRXP common stock S - Sale I 1.5046 -8,441 -13 9,634,793
2022-12-01 2022-11-29 4 Javitt Daniel C. by Glytech LLC NRXP common stock S - Sale I 1.5041 -13,730 -21 9,643,234
2022-11-29 2022-11-28 4 Flynn Patrick John NRXP Common Stock, par value $0.001 per share P - Purchase D 1.2500 1,750 2 1,750
2022-11-29 2022-11-28 4 Flynn Patrick John By Trust NRXP Common Stock, par value $0.001 per share P - Purchase I 1.2400 2,500 3 40,209
2022-11-29 2022-11-28 4 Flynn Patrick John By Trust NRXP Common Stock, par value $0.001 per share P - Purchase I 1.2500 2,500 3 37,709
2022-11-29 2022-11-28 4 Flynn Patrick John By Trust NRXP Common Stock, par value $0.001 per share P - Purchase I 1.2500 2,500 3 40,209
2022-11-29 2022-11-28 4 Flynn Patrick John By Trust NRXP Common Stock, par value $0.001 per share P - Purchase I 1.2500 2,500 3 37,709
2022-11-28 2022-11-25 4 VAN VOORHEES SETH Shares purchased though 401(k) plan NRXP Common Stock, par value $0.001 per share P - Purchase I 1.1100 7,021 8 16,377
2022-11-28 2022-11-25 4 VAN VOORHEES SETH Shares purchased though 401(k) plan NRXP Common Stock, par value $0.001 per share P - Purchase I 1.1000 600 1 9,316
2022-11-28 2022-11-25 4 VAN VOORHEES SETH Shares purchased though 401(k) plan NRXP Common Stock, par value $0.001 per share P - Purchase I 1.1200 8,716 10 8,716
2022-11-23 2022-11-18 4/A Hurvitz Chaim NRXP Common Stock P - Purchase D 1.1000 40,408 44 500,000
2022-11-23 2022-11-17 4/A Hurvitz Chaim NRXP Common Stock P - Purchase D 1.0800 171,780 186 459,592
2022-11-23 2022-11-16 4/A Hurvitz Chaim NRXP Common Stock P - Purchase D 0.9900 287,812 285 287,812
2022-11-21 2022-11-18 4 Hurvitz Chaim NRXP Common Stock P - Purchase D 1.1000 40,408 44 500,000
2022-11-21 2022-11-17 4 Hurvitz Chaim NRXP Common Stock P - Purchase D 1.0800 171,780 186 459,592
2022-11-21 2022-11-16 4 Hurvitz Chaim NRXP Common Stock P - Purchase D 0.9900 287,812 285 287,812
2022-11-18 2022-11-17 4 Javitt Daniel C. by Glytech LLC NRXP common stock S - Sale I 1.0523 -33,018 -35 9,656,964
2022-11-18 2022-11-16 4 Javitt Daniel C. by Glytech LLC NRXP common stock S - Sale I 1.0200 -133,719 -136 9,689,982
2022-11-15 2022-11-11 4 Javitt Daniel C. by Glytech LLC NRXP common stock S - Sale I 1.0063 -49,200 -50 9,823,701
2022-08-02 2022-07-29 4 Javitt Daniel C. by Glytech LLC NRXP Common Stock S - Sale I 1.0094 -784,063 -791 9,872,901
2022-07-22 3 Willard Stephen H NRXP Restricted Common Stock, par value $0.001 per share D 1,000,000
2022-07-05 2022-07-01 4 Javitt Daniel C. by Glytech LLC NRXP Common Stock G - Gift I -2,000,000 10,656,964
2022-06-07 2022-06-07 4 Javitt Daniel C. by Glytech LLC NRXP Common Stock S - Sale I 0.6461 -86,459 -56 12,656,964
2022-06-07 2022-06-06 4 Javitt Daniel C. by Glytech LLC NRXP Common Stock S - Sale I 0.6653 -115,657 -77 12,743,423
2022-06-07 2022-06-03 4 Javitt Daniel C. by Glytech LLC NRXP Common Stock S - Sale I 0.7024 -243,596 -171 12,859,080
2022-06-02 2022-06-01 4/A Javitt Jonathan C NRXP Common Stock P - Purchase D 0.5800 100,000 58 146,332
2022-06-02 2022-06-01 4 Javitt Jonathan C NRXP Common Stock P - Purchase D 58.0000 100,000 5,800 146,332
2022-03-10 2022-03-08 4 Besthof Robert NRXP Employee Stock Option A - Award D 2.61 2.6100 100,000 261 347,200
2021-11-02 2021-08-26 4 McMaster Herbert Raymond NRXP Restricted Stock Units A - Award D 10,424 10,424
2021-11-02 2021-08-26 4 McMaster Herbert Raymond NRXP Employee Stock Option (Right to buy) C - Conversion D 2.22 2.2200 -28,724 -64 16,362
2021-11-02 2021-08-26 4 McMaster Herbert Raymond NRXP Common Stock M - Exercise D 2.2200 18,300 41 18,300
2021-11-02 2021-09-02 4 Daigneault Alessandra NRXP Restricted Stock Units A - Award D 7,502 33,603
2021-11-02 2021-09-02 4 Daigneault Alessandra NRXP Restricted Stock Units A - Award D 10,496 26,101
2021-11-02 2021-09-02 4 Daigneault Alessandra NRXP Employee Stock Option (Right to buy) C - Conversion D 3.07 3.0700 -20,666 -63 28,934
2021-11-02 2021-09-02 4 Daigneault Alessandra NRXP Employee Stock Option (Right to buy) C - Conversion D 3.07 3.0700 -28,916 -89 71,924
2021-11-02 2021-09-02 4 Daigneault Alessandra NRXP Common Stock M - Exercise D 3.0700 13,164 40 31,584
2021-11-02 2021-09-02 4 Daigneault Alessandra NRXP Common Stock M - Exercise D 3.0700 18,420 57 18,420
2021-11-02 2021-08-23 4 Daigneault Alessandra NRXP Common Stock S - Sale D 13.1100 -33,715 -442 0
2021-11-02 2021-08-19 4 Daigneault Alessandra NRXP Restricted Stock Units A - Award D 15,605 15,605
2021-11-02 2021-08-19 4 Daigneault Alessandra NRXP Employee Stock Option (Right to buy) C - Conversion D 3.07 3.0700 -43,000 -132 100,840
2021-11-02 2021-08-19 4 Daigneault Alessandra NRXP Common Stock M - Exercise D 3.0700 27,395 84 33,715
2021-11-02 2021-07-16 4 Javitt Daniel C. By Glytech LLC NRXP Common Stock G - Gift I -434,594 13,102,676
2021-11-02 2021-07-16 4 Javitt Daniel C. By Glytech LLC NRXP Common Stock G - Gift I -434,594 13,102,676
2021-11-02 2021-09-15 4 Besthof Robert NRXP Common Stock S - Sale D 11.7600 -40,000 -470 23,710
2021-11-02 2021-08-16 4 Besthof Robert NRXP Restricted Stock Units A - Award D 36,290 36,290
2021-11-02 2021-08-16 4 Besthof Robert NRXP Employee Stock Option (Right to buy) C - Conversion D 0.20 0.2000 -100,000 -20 247,200
2021-11-02 2021-08-16 4 Besthof Robert NRXP Common Stock M - Exercise D 0.2000 63,710 13 63,710
2021-06-10 2021-05-24 4 Troy Daniel NRXP Employee Stock Option (Right to buy) A - Award D 2.18 65,437 65,437
2021-06-10 2021-05-24 4 Troy Daniel NRXP Common Stock A - Award D 43,093 43,093
2021-06-10 2021-05-24 4 Javitt Daniel C. By LLC NRXP Common Stock A - Award I 13,971,864 13,971,864
2021-06-10 2021-05-24 4 Javitt Jonathan C By Trust NRXP Common Stock A - Award I 1,422,000 1,422,000
2021-06-10 2021-05-24 4 Javitt Jonathan C By Trust NRXP Common Stock A - Award I 13,348,997 13,348,997
2021-06-10 2021-05-24 4 Javitt Jonathan C NRXP Common Stock A - Award D 46,332 46,332
2021-06-10 2021-05-24 4 Glied Sharon NRXP Employee Stock Option (Right to buy) A - Award D 0.21 65,437 65,437
2021-06-10 2021-05-24 4 Glied Sharon NRXP Common Stock A - Award I 13,168 13,168
2021-06-10 2021-05-24 4 Gorovitz Aaron By spouse NRXP Common Stock A - Award I 16,678 16,678
2021-06-10 2021-05-24 4 Gorovitz Aaron By Trust NRXP Common Stock A - Award I 8,336 8,336
2021-06-10 2021-05-24 4 Gorovitz Aaron By Trust NRXP Common Stock A - Award I 8,336 8,336
2021-06-10 2021-05-24 4 Gorovitz Aaron By Trust NRXP Common Stock A - Award I 8,336 8,336
2021-06-10 2021-05-24 4 Hurvitz Chaim NRXP Common Stock Warrant (Right to buy) A - Award I 1.53 218,423 218,423
2021-06-10 2021-05-24 4 Hurvitz Chaim NRXP Common Stock A - Award I 208,443 208,443
2021-06-10 2021-05-24 4 Hurvitz Chaim NRXP Common Stock A - Award I 1,436,350 1,436,350
2021-06-10 2021-05-24 4 Flynn Patrick John By Trust NRXP Common Stock Warrant (Right to buy) A - Award I 3.08 692,639 692,639
2021-06-10 2021-05-24 4 Flynn Patrick John By Trust NRXP Common Stock Warrant (Right to buy) A - Award I 3.08 692,639 692,639
2021-06-10 2021-05-24 4 Flynn Patrick John By Trust NRXP Common Stock A - Award I 35,209 35,209
2021-06-10 2021-05-24 4 Flynn Patrick John By Trust NRXP Common Stock A - Award I 35,209 35,209
2021-06-10 2021-05-24 4 Flynn Patrick John By LLC NRXP Common Stock A - Award I 362,332 362,332
2021-06-10 2021-05-24 4 Fricker William NRXP Employee Stock Option (Right to buy) A - Award D 3.08 99,200 198,400
2021-06-10 2021-05-24 4 Fricker William NRXP Employee Stock Option (Right to buy) A - Award D 3.08 99,200 198,400
2021-06-10 2021-05-24 4 Daigneault Alessandra NRXP Employee Stock Option (Right to buy) A - Award D 72.30 148,800 148,800
2021-06-10 2021-05-24 4 Daigneault Alessandra NRXP Employee Stock Option (Right to buy) A - Award D 3.08 49,600 49,600
2021-06-10 2021-05-24 4 Daigneault Alessandra NRXP Employee Stock Option (Right to buy) A - Award D 3.08 143,840 143,840
2021-06-10 2021-05-24 4 Daigneault Alessandra NRXP Common Stock A - Award D 6,320 6,320
2021-06-10 2021-05-24 4 Besthof Robert NRXP Employee Stock Option (Right to buy) A - Award D 0.21 347,200 347,200
2021-06-10 2021-05-24 4 Besthof Robert NRXP Employee Stock Option (Right to buy) A - Award D 3.08 347,200 347,200
2021-06-04 2021-05-24 4/A BRAC Lending Group LLC BRPA Common Stock D - Sale to Issuer D -869,565 590,435
2021-05-25 2021-05-24 4 Big Rock Partners Sponsor, LLC By A/Z Property Partners LLC BRPA Unit Purchase Option P - Purchase I 10.00 1.0000 100,000 100 100,000
2021-05-25 2021-05-24 4 Big Rock Partners Sponsor, LLC By Big Rock Partners Sponsor, LLC BRPA Rights, exchangeable for Common Stock C - Conversion I -272,500 0
2021-05-25 2021-05-24 4 Big Rock Partners Sponsor, LLC By Big Rock Partners Sponsor, LLC BRPA Common Stock C - Conversion I 27,250 519,315
2021-05-25 2021-05-24 4 Big Rock Partners Sponsor, LLC By Big Rock Partners Sponsor, LLC BRPA Common Stock D - Sale to Issuer I -5,435 492,065
2021-05-25 2021-05-24 4 BRAC Lending Group LLC BRPA Common Stock D - Sale to Issuer D -869,565 562,435
2020-03-17 2020-03-13 4 Polar Asset Management Partners Inc. BRPA Common Stock, par value $0.001 per share S - Sale I 10.6000 -29,464 -312 488,036
2020-03-06 3 Polar Asset Management Partners Inc. See footnote 1 BRPA Common Stock, par value $0.001 per share I 1,035,000
2020-03-06 3 Polar Asset Management Partners Inc. See footnote 1 BRPA Common Stock, par value $0.001 per share I 1,035,000
2020-03-06 3 Polar Asset Management Partners Inc. See footnote 1 BRPA Common Stock, par value $0.001 per share I 1,035,000
2018-11-26 3 Levine Steven Held by BRAC Lending Group LLC BRPA Common Stock I 3,138,000
2018-11-26 3 Levine Steven Held by BRAC Lending Group LLC BRPA Common Stock I 3,138,000
2018-11-26 3 Levine Steven Held by EarlyBirdCapital, Inc. BRPA Common Stock I 1,776,000
2018-11-26 3 Levine Steven Held by BRAC Lending Group LLC BRPA Common Stock I 3,138,000
2018-11-26 3 Levine Steven Held by EarlyBirdCapital, Inc. BRPA Common Stock I 1,776,000
2018-11-26 3 Levine Steven Held by EarlyBirdCapital, Inc. BRPA Common Stock I 1,776,000
2018-11-26 3 Levine Steven Held by BRAC Lending Group LLC BRPA Common Stock I 3,138,000
2018-11-26 3 Levine Steven Held by EarlyBirdCapital, Inc. BRPA Common Stock I 1,776,000
2018-11-26 3 Levine Steven Held by EarlyBirdCapital, Inc. BRPA Common Stock I 1,776,000
2018-11-26 3 Levine Steven Held by BRAC Lending Group LLC BRPA Common Stock I 3,138,000
2018-11-20 2018-11-20 4 ACKERMAN RICHARD Big Rock Partners Sponsor, LLC BRPA Common Stock S - Sale I -1,500,000 225,000
2017-12-04 3 BIRDOFF RICHARD BRPAU No securities are beneficially owned D 0
2017-12-04 3 ACKERMAN RICHARD By Big Rock Partners Sponsor, LLC BRPAU Common Stock I 2,225,000
2017-12-04 3 ACKERMAN RICHARD By Big Rock Partners Sponsor, LLC BRPAU Common Stock I 3,700,000
2017-12-04 3 ACKERMAN RICHARD By Big Rock Partners Sponsor, LLC BRPAU Common Stock I 3,700,000
2017-12-04 3 ACKERMAN RICHARD By Big Rock Partners Sponsor, LLC BRPAU Common Stock I 2,225,000
2017-12-04 3 ACKERMAN RICHARD By Big Rock Partners Sponsor, LLC BRPAU Common Stock I 3,700,000
2017-12-04 3 ACKERMAN RICHARD By Big Rock Partners Sponsor, LLC BRPAU Common Stock I 2,225,000
2017-12-04 3 REX ALBERT G. BRPAU Common Stock I 0
2017-12-04 3 FONG MICHAEL BRPAU Common Stock I 0
2017-12-04 3 Wittman Lori BRPAU Common Stock I 0
2017-12-04 3 Koenig Stuart F. BRPAU No securities are beneficially owned. D 0
2017-12-04 3 Taylor Troy T BRPAU Common Stock I 0
2017-12-04 2017-11-29 4 ACKERMAN RICHARD Big Rock Partners Sponsor, LLC BRPAU Warrant P - Purchase I 11.50 11,250 136,250
2017-12-04 2017-11-29 4 ACKERMAN RICHARD Big Rock Partners Sponsor, LLC BRPAU Right to receive common stock P - Purchase I 22,500 27,250
2017-12-04 2017-11-29 4 ACKERMAN RICHARD Big Rock Partners Sponsor, LLC BRPAU Common Stock P - Purchase I 10.0000 22,500 225 272,500
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:B1Q €3.67
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista